Trulicity autoinjector pens recalled for incorrect strength labeling
Eli Lilly & Company is recalling Trulicity (dulaglutide) 0.75 mg autoinjector pens because some contain double the labeled strength. Affected patients may receive an incorrect dose.
- Product
- TRULICITY — TRULICITY (DULAGLUTIDE)
- Category
- Drug
- Distribution
- Distributed nationwide